Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    ald403
Show Display Options
Rank Status Study
1 Completed Safety, Efficacy and Pharmacokinetics of ALD403
Condition: Migraine
Interventions: Biological: ALD403;   Drug: Placebo
2 Completed Safety Tolerability and Pharmacokinetics of ALD403
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Sumatriptan
3 Completed A Multicenter Assessment of ALD403 in Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403;   Biological: Placebo
4 Active, not recruiting An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine
Condition: Migraine Disorder
Intervention: Biological: ALD403 (Eptinezumab)
5 Recruiting Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine
Condition: Migraine Disorders
Interventions: Biological: ALD403 (Eptinezumab);   Biological: Placebo
6 Active, not recruiting A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
Condition: Migraine Disorders
Interventions: Drug: ALD403;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.